Kipp Weiskopf
Beth Israel Deaconess Medical Center · 106 works · 8,116 citations · h-index 27
Top works
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center
- Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
- Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
- Cancer immunotherapy targeting the CD47/SIRPα axis
- Asterless is a scaffold for the onset of centriole assembly
- Macrophages are critical effectors of antibody therapies for cancer
- Targeting CD137 enhances the efficacy of cetuximab
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
- A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated Macrophages
- Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
- A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
- Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors